Icahn Said to Build Sizable Cigna Stake

The transcript discusses the upcoming vote on Cigna's acquisition of Express Scripts, highlighting shareholder concerns and the influence of major players like Amazon. It examines the market's reaction, investor expectations, and the potential for renegotiation or opposition to the deal. The discussion also covers industry trends, such as consolidation in healthcare, and Cigna's strategic options, including the possibility of selling itself.

What is the primary role of Express Scripts in the healthcare industry?

• A medical equipment supplier

• A healthcare provider

• A pharmacy benefits manager

• A pharmaceutical manufacturer

What is one of the main concerns investors have about Cigna's acquisition of Express Scripts?

• The declining value of Express Scripts

• The potential for increased competition

• The lack of synergy between the companies

• The high cost of the acquisition

What is the merger arbitrage spread mentioned in the context of the Cigna-Express Scripts deal?

• 40-45%

• 10-15%

• 20-25%

• 30-35%

What strategic question is Cigna facing in the context of industry consolidation?

• Whether to expand internationally

• Whether to focus on digital health

• Whether to be a buyer or seller

• Whether to diversify into pharmaceuticals

What has been Carl Icahn's approach in similar situations in the past?

• Reducing company workforce

• Investing in new technologies

• Pushing for company sales

• Supporting management decisions